CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.35 From SG$0.32, Keeps at Add
CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.35 From SG$0.32, Keeps at Add
CGS-CIMB將Hyphens Pharma的目標股價從0.32新加坡元調整至0.35新加坡元,保持漲勢
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊